Indeed, engineered CDK2, but not CDK9 over-expression, reversed the presence of cancer cells having multipolar mitoses or chromosome ring formations after treatment with CYC065 or transfection of siRNAs that targeted CDK2. The gene discussed is CDK9; the disease is cancer.